Tokyo Tape
Sign in
5% STAKE4594.TTSECAYMAN ISLANDS

Evo Fund lowers stake in BrightPath Biotherapeutics to 22.31%

Stake history

20%22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF22.31%Aug 14Aug 14: 22.31% · S100U7QN
20%22%24%26%24.41%PriorPrior: 24.41% · prior ratio stated in S100U3IF23.14%Jul 25Jul 25: 23.14% · S100U3IF22.31%Aug 14Aug 14: 22.31% · S100U7QN

Summary

Evo Fund and joint holders filed a Change in 5%+ stake (change report) via EDINET on 2024-08-14 10:55 JST concerning BrightPath Biotherapeutics Co., Ltd. Reported holding ratio: 22.31%, previous report: 23.14%.

Stock price4594 · View chart ↗

Open the price chart on TradingView.

Source: EDINET S100U7QN ↗ · PDL1.0 · Not investment advice